Home › Researcher directory › Joel Charrow

Joel Charrow

Affiliation : Northwestern University · Lurie Children's Hospital

• 2Publications (affiliation in the United States)
• 244Total publications
• 12268Citations
• 57h-index

ORCIDOpenAlex

Research profile

Joel Charrow has 2 indexed publications (2018–2019). Their work appears in “Blood Cells Molecules and Diseases”. Their most cited article, “Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1” (2018), has been cited 29 times. Their work is co-authored with at least 5 researchers.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Metabolism and Genetic Disorders
• Lysosomal Storage Disorders Research
• Glycogen Storage Diseases and Myoclonus
• Neurofibromatosis and Schwannoma Cases
• Genomics and Rare Diseases

Publications (2)

• Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
  2019 · Blood Cells Molecules and Diseases · cited 2 times
• Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
  2018 · Blood Cells Molecules and Diseases · cited 29 times

Publications per year

• 20191
• 20181

Collaborations

Partner institutions : New York University · Cedars-Sinai Medical Center · Icahn School of Medicine at Mount Sinai · Duke University · Yale University

Co-authors

• Pramod Kumar Mistry
• Priya Sunil Kishnani
• Manisha Balwani
• Barry E. Rosenbloom
• Gregory M. Pastores

Bibliographic data from OpenAlex (open database).